Fig. 1 · Structure
Documents & Downloads
Capecitabine-d11
Stable Isotope
Capecitabine-d11 is a deuterium-labeled derivative of Capecitabine, an oral prodrug that is metabolically converted to the active compound 5-fluorouracil (5-FU) by thymidine phosphorylase. This stable isotope variant enables the study of drug metabolism and pharmacokinetics within biological systems, making it a valuable tool in cancer research and therapeutic monitoring. Researchers can utilize Capecitabine-d11 to enhance the specificity and accuracy of metabolic studies involving 5-FU.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1132662-08-8 |
| Applications | Stable Isotope |
| Formula | C15H11D11FN3O6 |
| Molecular Weight | 370.42 |
| SMILES | C[C@@H]1[C@H]([C@H]([C@H](N2C(N=C(C(F)=C2)NC(OC([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)=O)O1)O)O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.